-
Long-Term Impact of Emicizumab in Hemophilia A (HA): Analysis by Inhibitor Status in Three Latin American (LATAM) Countries
Sep 9, 2025, 16:22 PM -
Spillover Effect in Health Utility Values: A Systematic Review
Sep 9, 2025, 16:22 PM -
Timing Matters: Missed Opportunity to Prevent RSV Cases in Older Adults in Germany: A Markov Model Analysis
Sep 9, 2025, 16:22 PM -
Navigating Evidence Requirements for Joint Clinical Assessment (JCA): Practical Considerations for Systematic Literature Review (SLR) and Indirect Treatment Comparisons (ITCs)
Sep 9, 2025, 16:22 PM -
Cost-Utility Analysis of Pegunigalsidase Alfa Compared to Agalsidase Alfa and Agalsidase Beta for the Treatment of Adult Patients With Fabry Disease in Greece
Sep 9, 2025, 16:22 PM -
Epidemiology of Diabetes Mellitus in Pregnancy in Hungary: Trends and Future Projections
Sep 9, 2025, 16:22 PM -
What Tips the Scale Toward Reimbursement? A Dutch-led Comparison of Pharmacoeconomic Evaluations Across the Netherlands, Sweden, and the United Kingdom
Sep 9, 2025, 16:22 PM -
Mapping the Evidence on Interrelationships Between Cancer Stage Financial Toxicity (FT) and Health-Related Quality of Life (HRQoL)
Sep 9, 2025, 16:22 PM -
A Gap Analysis of HTA Methods in Europe: Results From SUSTAIN-HTA
Sep 9, 2025, 16:22 PM -
Examining the Trade-off of Breastfeeding vs. Semaglutide Use After Childbirth
Sep 9, 2025, 16:22 PM -
Feasibility of Indication-Specific Pricing for Life Cycle Management of an Innovative Rare Disease Product
Sep 9, 2025, 16:22 PM -
From JCA to Local PR: Evaluating Impact Across Europe
Sep 9, 2025, 16:22 PM -
Constructing a Dynamic Budget Impact Model: An AI Pretraining Approach for a New Parkinson's Disease Drug
Sep 9, 2025, 16:22 PM -
Population-Level Impact of Emicizumab in Algeria: A 25-Year Projection
Sep 9, 2025, 16:22 PM -
Advancing the Science of Qualitative Patient Preference Assessment Using Large Language Models
Sep 9, 2025, 16:22 PM -
Optimizing Therapeutic Strategies for Multiple Sclerosis in Italy: A Budget Impact Analysis
Sep 9, 2025, 16:22 PM -
Predictive Algorithms in HTA: What Factors Influence Decision Making in NICE, SMC, and NCPE?
Sep 9, 2025, 16:22 PM -
Development and Validation of an Automated Cancer Stage Classifier for Real-World Oncology Data Mapped to the OMOP Common Data Model
Sep 9, 2025, 16:22 PM -
A Scoping Review of Resource Modeling in HTA Using Discrete Event Simulation
Sep 9, 2025, 16:22 PM -
Synthetic Data Generation vs. Simulated Treatment Comparison: Assessment of the Performance of a Novel Approach for Unanchored Indirect Treatment Comparisons
Sep 9, 2025, 16:22 PM
